Regulations for Good Clinical Practice Article 113
If the investigator suspended or terminated a trial without prior agreement of the sponsor, the investigator and the institution shall promptly inform the sponsor and the Ethics Committee, and provide detailed written reports.
中文原文 藥品優良臨床試驗作業準則第113條
試驗主持人及試驗機構未事先獲得試驗委託者之同意，而中止或終止臨床試驗者，試驗主持人及試驗機構應立即通知試驗委託者與人體試驗委員會，並提出詳細書面報告。